1. Saez A, Gonzalez-Granado JM: Recent Advances in Intermediate Filaments-Volume 1. Int J Mol Sci 2022, 23.
2. Jacob JT, Coulombe PA, Kwan R, Omary MB: Types I and II Keratin Intermediate Filaments. Cold Spring Harb Perspect Biol 2018, 10.
3. Usman S, Waseem NH, Nguyen TKN, Mohsin S, Jamal A, Teh MT, Waseem A: Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis. Cancers (Basel) 2021, 13.
4. Liu CY, Lin HH, Tang MJ, Wang YK: Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation. Oncotarget 2015, 6:15966-15983.
5. Yamashita N, Tokunaga E, Kitao H, Hisamatsu Y, Taketani K, Akiyoshi S, Okada S, Aishima S, Morita M, Maehara Y: Vimentin as a poor prognostic factor for triple-negative breast cancer. J Cancer Res Clin Oncol 2013, 139:739-746.
6. Shi R, Liu L, Wang F, He Y, Niu Y, Wang C, Zhang X, Zhang X, Zhang H, Chen M, Wang Y: Downregulation of cytokeratin 18 induces cellular partial EMT and stemness through increasing EpCAM expression in breast cancer. Cell Signal 2020, 76:109810.
7. Velez-delValle C, Marsch-Moreno M, Castro-Munozledo F, Galvan-Mendoza IJ, Kuri-Harcuch W: Epithelial cell migration requires the interaction between the vimentin and keratin intermediate filaments. Sci Rep 2016, 6:24389.
8. Steinert PM, Marekov LN, Parry DA: Diversity of intermediate filament structure. Evidence that the alignment of coiled-coil molecules in vimentin is different from that in keratin intermediate filaments. J Biol Chem 1993, 268:24916-24925.
9. Biskou O, Casanova V, Hooper KM, Kemp S, Wright GP, Satsangi J, Barlow PG, Stevens C: The type III intermediate filament vimentin regulates organelle distribution and modulates autophagy. PLoS One 2019, 14:e0209665.
10. Keeling MC, Flores LR, Dodhy AH, Murray ER, Gavara N: Actomyosin and vimentin cytoskeletal networks regulate nuclear shape, mechanics and chromatin organization. Sci Rep 2017, 7:5219.
11. Gao Y, Sztul E: A novel interaction of the Golgi complex with the vimentin intermediate filament cytoskeleton. J Cell Biol 2001, 152:877-894.
12. Chang L, Barlan K, Chou YH, Grin B, Lakonishok M, Serpinskaya AS, Shumaker DK, Herrmann H, Gelfand VI, Goldman RD: The dynamic properties of intermediate filaments during organelle transport. J Cell Sci 2009, 122:2914-2923.
13. Matveeva EA, Chernoivanenko IS, Minin AA: Vimentin intermediate filaments protect mitochondria from oxidative stress. Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology 2010, 4:321-331.
14. Lian N, Wang W, Li L, Elefteriou F, Yang X: Vimentin inhibits ATF4-mediated osteocalcin transcription and osteoblast differentiation. J Biol Chem 2009, 284:30518-30525.
15. Perez-Sala D, Oeste CL, Martinez AE, Carrasco MJ, Garzon B, Canada FJ: Vimentin filament organization and stress sensing depend on its single cysteine residue and zinc binding. Nat Commun 2015, 6:7287.
16. Pattabiraman S, Azad GK, Amen T, Brielle S, Park JE, Sze SK, Meshorer E, Kaganovich D: Vimentin protects differentiating stem cells from stress. Sci Rep 2020, 10:19525.
17. Challa AA, Stefanovic B: A novel role of vimentin filaments: binding and stabilization of collagen mRNAs. Mol Cell Biol 2011, 31:3773-3789.
18. Ostrowska-Podhorodecka Z, Ding I, Norouzi M, McCulloch CA: Impact of Vimentin on Regulation of Cell Signaling and Matrix Remodeling. Front Cell Dev Biol 2022, 10:869069.
19. Terriac E, Coceano G, Mavajian Z, Hageman TA, Christ AF, Testa I, Lautenschlager F, Gad AK: Vimentin Levels and Serine 71 Phosphorylation in the Control of Cell-Matrix Adhesions, Migration Speed, and Shape of Transformed Human Fibroblasts. Cells 2017, 6.
20. Burgstaller G, Gregor M, Winter L, Wiche G: Keeping the vimentin network under control: cell-matrix adhesion-associated plectin 1f affects cell shape and polarity of fibroblasts. Mol Biol Cell 2010, 21:3362-3375.
21. Kim H, Nakamura F, Lee W, Shifrin Y, Arora P, McCulloch CA: Filamin A is required for vimentin-mediated cell adhesion and spreading. Am J Physiol Cell Physiol 2010, 298:C221-236.
22. Correia I, Chu D, Chou YH, Goldman RD, Matsudaira P: Integrating the actin and vimentin cytoskeletons. adhesion-dependent formation of fimbrin-vimentin complexes in macrophages. J Cell Biol 1999, 146:831-842.
23. Patteson AE, Carroll RJ, Iwamoto DV, Janmey PA: The vimentin cytoskeleton: when polymer physics meets cell biology. Phys Biol 2020, 18:011001.
24. Burke B, Stewart CL: The nuclear lamins: flexibility in function. Nat Rev Mol Cell Biol 2013, 14:13-24.
25. Georgatos SD, Blobel G: Lamin B constitutes an intermediate filament attachment site at the nuclear envelope. J Cell Biol 1987, 105:117-125.
26. Vahabikashi A, Sivagurunathan S, Nicdao FAS, Han YL, Park CY, Kittisopikul M, Wong X, Tran JR, Gundersen GG, Reddy KL, et al: Nuclear lamin isoforms differentially contribute to LINC complex-dependent nucleocytoskeletal coupling and whole-cell mechanics. Proc Natl Acad Sci U S A 2022, 119:e2121816119.
27. Messica Y, Laser-Azogui A, Volberg T, Elisha Y, Lysakovskaia K, Eils R, Gladilin E, Geiger B, Beck R: The role of Vimentin in Regulating Cell Invasive Migration in Dense Cultures of Breast Carcinoma Cells. Nano Lett 2017, 17:6941-6948.
28. Mendez MG, Kojima S, Goldman RD: Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition. FASEB J 2010, 24:1838-1851.
29. Vuoriluoto K, Haugen H, Kiviluoto S, Mpindi JP, Nevo J, Gjerdrum C, Tiron C, Lorens JB, Ivaska J: Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene 2011, 30:1436-1448.
30. Paccione RJ, Miyazaki H, Patel V, Waseem A, Gutkind JS, Zehner ZE, Yeudall WA: Keratin down-regulation in vimentin-positive cancer cells is reversible by vimentin RNA interference, which inhibits growth and motility. Mol Cancer Ther 2008, 7:2894-2903.
31. Hendrix MJ, Seftor EA, Seftor RE, Trevor KT: Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. Am J Pathol 1997, 150:483-495.
32. Aldehlawi H, Usman S, Lalli A, Ahmad F, Williams G, Teh MT, Waseem A: Serum lipids, retinoic acid and phenol red differentially regulate expression of keratins K1, K10 and K2 in cultured keratinocytes. Sci Rep 2020, 10:4829.
33. Usman S, Aldehlawi H, Nguyen TKN, Teh MT, Waseem A: Impact of N-Terminal Tags on De Novo Vimentin Intermediate Filament Assembly. Int J Mol Sci 2022, 23.
34. Rueden CT, Schindelin J, Hiner MC, DeZonia BE, Walter AE, Arena ET, Eliceiri KW: ImageJ2: ImageJ for the next generation of scientific image data. BMC Bioinformatics 2017, 18:529.
35. Edelheit O, Hanukoglu A, Hanukoglu I: Simple and efficient site-directed mutagenesis using two single-primer reactions in parallel to generate mutants for protein structure-function studies. BMC Biotechnol 2009, 9:61.
36. Swift S, Lorens J, Achacoso P, Nolan GP: Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. Curr Protoc Immunol 2001, Chapter 10:Unit 10 17C.
37. Aldehlawi H, Niemiec KA, Avisetti DR, Lalli A, Teh MT, Waseem A: The monoclonal antibody EPR1614Y against the stem cell biomarker keratin K15 lacks specificity and reacts with other keratins. Sci Rep 2019, 9:1943.
38. Kumar P, Nagarajan A, Uchil PD: Analysis of Cell Viability by the MTT Assay. Cold Spring Harb Protoc 2018, 2018.
39. Chavez KJ, Garimella SV, Lipkowitz S: Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer. Breast Dis 2010, 32:35-48.
40. Polioudaki H, Agelaki S, Chiotaki R, Politaki E, Mavroudis D, Matikas A, Georgoulias V, Theodoropoulos PA: Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer. BMC Cancer 2015, 15:399.
41. Thomas PA, Kirschmann DA, Cerhan JR, Folberg R, Seftor EA, Sellers TA, Hendrix MJ: Association between keratin and vimentin expression, malignant phenotype, and survival in postmenopausal breast cancer patients. Clin Cancer Res 1999, 5:2698-2703.
42. Langa F, Kress C, Colucci-Guyon E, Khun H, Vandormael-Pournin S, Huerre M, Babinet C: Teratocarcinomas induced by embryonic stem (ES) cells lacking vimentin: an approach to study the role of vimentin in tumorigenesis. J Cell Sci 2000, 113 Pt 19:3463-3472.
43. Li ZM, Wen YJ, Yang HB, Qin G, Tian L, Deng HX, Wen B: [Enhanced expression of human vimentin intermediate filaments in hepatocellular carcinoma cells decreases their proliferative and invasive abilities in vitro]. Zhonghua Zhong Liu Za Zhi 2008, 30:408-412.
44. Kim J, Jang J, Yang C, Kim EJ, Jung H, Kim C: Vimentin filament controls integrin alpha5beta1-mediated cell adhesion by binding to integrin through its Ser38 residue. FEBS Lett 2016, 590:3517-3525.
45. Havel LS, Kline ER, Salgueiro AM, Marcus AI: Vimentin regulates lung cancer cell adhesion through a VAV2-Rac1 pathway to control focal adhesion kinase activity. Oncogene 2015, 34:1979-1990.
46. McInroy L, Maatta A: Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion. Biochem Biophys Res Commun 2007, 360:109-114.
47. Chu YW, Seftor EA, Romer LH, Hendrix MJ: Experimental coexpression of vimentin and keratin intermediate filaments in human melanoma cells augments motility. Am J Pathol 1996, 148:63-69.
48. Zhang Y, Stefanovic B: LARP6 Meets Collagen mRNA: Specific Regulation of Type I Collagen Expression. Int J Mol Sci 2016, 17:419.
49. Tsuruta D, Jones JC: The vimentin cytoskeleton regulates focal contact size and adhesion of endothelial cells subjected to shear stress. J Cell Sci 2003, 116:4977-4984.
50. Ostrowska-Podhorodecka Z, Ding I, Lee W, Tanic J, Abbasi S, Arora PD, Liu RS, Patteson AE, Janmey PA, McCulloch CA: Vimentin tunes cell migration on collagen by controlling beta1 integrin activation and clustering. J Cell Sci 2021, 134.
51. Huang B, Lu M, Jolly MK, Tsarfaty I, Onuchic J, Ben-Jacob E: The three-way switch operation of Rac1/RhoA GTPase-based circuit controlling amoeboid-hybrid-mesenchymal transition. Sci Rep 2014, 4:6449.
52. van Engeland NCA, Suarez Rodriguez F, Rivero-Muller A, Ristori T, Duran CL, Stassen O, Antfolk D, Driessen RCH, Ruohonen S, Ruohonen ST, et al: Vimentin regulates Notch signaling strength and arterial remodeling in response to hemodynamic stress. Sci Rep 2019, 9:12415.
53. Wang PW, Wu TH, Lin TY, Chen MH, Yeh CT, Pan TL: Characterization of the Roles of Vimentin in Regulating the Proliferation and Migration of HSCs during Hepatic Fibrogenesis. Cells 2019, 8.
54. Xiong D, Sheng Y, Ding S, Chen J, Tan X, Zeng T, Qin D, Zhu L, Huang A, Tang H: LINC00052 regulates the expression of NTRK3 by miR-128 and miR-485-3p to strengthen HCC cells invasion and migration. Oncotarget 2016, 7:47593-47608.
55. Mirza MK, Sun Y, Zhao YD, Potula HH, Frey RS, Vogel SM, Malik AB, Zhao YY: FoxM1 regulates re-annealing of endothelial adherens junctions through transcriptional control of beta-catenin expression. J Exp Med 2010, 207:1675-1685.
56. Li L, Backer J, Wong AS, Schwanke EL, Stewart BG, Pasdar M: Bcl-2 expression decreases cadherin-mediated cell-cell adhesion. J Cell Sci 2003, 116:3687-3700.
57. Sivagurunathan S, Vahabikashi A, Yang H, Zhang J, Vazquez K, Rajasundaram D, Politanska Y, Abdala-Valencia H, Notbohm J, Ming Guo M, et al: Expression of vimentin alters cell mechanics, cell-cell adhesion, and gene expression profiles suggesting the induction of a hybrid EMT in human mammary epithelial cells. Front Cell Dev Biol 2022.
58. Bouzid T, Kim E, Riehl BD, Esfahani AM, Rosenbohm J, Yang R, Duan B, Lim JY: The LINC complex, mechanotransduction, and mesenchymal stem cell function and fate. J Biol Eng 2019, 13:68.
59. Shin JY, Worman HJ: Molecular Pathology of Laminopathies. Annu Rev Pathol 2022, 17:159-180.
60. Parry DA, Martin CA, Greene P, Marsh JA, Genomics England Research C, Blyth M, Cox H, Donnelly D, Greenhalgh L, Greville-Heygate S, et al: Heterozygous lamin B1 and lamin B2 variants cause primary microcephaly and define a novel laminopathy. Genet Med 2021, 23:408-414.
61. Dubik N, Mai S: Lamin A/C: Function in Normal and Tumor Cells. Cancers (Basel) 2020, 12.
62. Patteson AE, Vahabikashi A, Pogoda K, Adam SA, Mandal K, Kittisopikul M, Sivagurunathan S, Goldman A, Goldman RD, Janmey PA: Vimentin protects cells against nuclear rupture and DNA damage during migration. J Cell Biol 2019, 218:4079-4092.
63. Turgay Y, Eibauer M, Goldman AE, Shimi T, Khayat M, Ben-Harush K, Dubrovsky-Gaupp A, Sapra KT, Goldman RD, Medalia O: The molecular architecture of lamins in somatic cells. Nature 2017, 543:261-264.